EPHA3 enhances macrophage autophagy and apoptosis by disrupting the mTOR signaling pathway in mice with endometriosis
article
OA: gold
CC0
⤵ 11 in-corpus citations
AI-generated summary
EPHA3 overexpression inhibited the mTOR pathway, promoting macrophage autophagy and apoptosis in mouse models of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Abstract Background: Endometriosis is a chronic fibrotic disease characterized by agonizing pelvic pain and low fertility, mainly affecting middle-aged women. The aim of the present study is to assess the potential effects of erythropoietin-producing hepatocellular carcinoma A3 (EPHA3) on endometriosis, with emphasis on the autophagy and apoptosis of macrophages via inhibition of the mammalian target of rapamycin (mTOR) signaling pathway. Methods: The mouse models of endometriosis were established followed by culturing the macrophages and macrophage transfection via the EPHA3 vector, siRNA EPHA3, and RAPA (an inhibitor of the mTOR signaling pathway). The expression of EPHA3, related factors in the mTOR signaling pathway, macrophage autophagy (autophagy-related gene 3 (Atg3), light chain 3-I (LC3-I), light chain 3-II (LC3-II) and Beclin1) and apoptosis (B-cell lymphoma-2 (bcl-2), bax and fas) were all detected and documented, respectively. The changes of autophagic lysosomes and the apoptosis of macrophages in each group following transfection were also inspected and detected. Results: The results of the in silico analysis ascertained EPHA3 to be a candidate gene of endometriosis. After successful modeling, the uterine tissues of endometriosis mice presented with a low expression of EPHA3 and activated mTOR signaling pathway. Overexpression of EPHA3 inhibited the activation of the mTOR signaling pathway, down-regulated bcl-2 expression, up-regulated the expression of Atg3, LC3-II/LC3-I, Beclin1, bax and fas, and also promoted the autophagy and apoptosis of macrophages in endometriosis mice. Conclusion: Altogether, EPHA3 could potentially promote the autophagy and apoptosis of macrophages in endometriosis via inhibition of the mTOR signaling pathway, highlighting the potential of EPHA3 as the target to treat endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis via openalex
- Endometriosis: Epidemiology, Diagnosis and Clinical Management via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members via openalex
- Exogenous activated NK cells enhance trafficking of endogenous NK cells to endometriotic lesions via openalex
- Hypoxia-inducible factor-1α promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis via openalex
- Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis via openalex
- mTor Inhibitors for the Treatment of Endometriosis via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life via openalex
- Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies via openalex
- W2038385234 via openalex
- W2048030072 via openalex
- W2049615458 via openalex
- W2085776608 via openalex
- W2109034822 via openalex
- W346499765 via openalex
- W2152910765 via openalex
- W2155295856 via openalex
- W2170916168 via openalex
- W2337998445 via openalex
- W2345896299 via openalex
- W2399977168 via openalex
- W2477326720 via openalex
- W2560536820 via openalex
- W2608827021 via openalex
- W2793391613 via openalex
- W2805693787 via openalex
- W2126904458 via openalex
- W1523693806 via openalex
- W1586151303 via openalex
- W1978194521 via openalex
- W1992954695 via openalex
- W2001083548 via openalex
- W2001675597 via openalex
- W2014338423 via openalex
- W2028744406 via openalex
- W2031984119 via openalex
- W2036406012 via openalex
- W2036459481 via openalex
Cited by (11)
- Targeting EphA2 suppresses the proliferation, migration and invasion of endometriosis <i>via</i> the AMPK signaling pathway 2025
- Focusing on the role of protein kinase mTOR in endometrial physiology and pathology: insights for therapeutic interventions 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- The mysterious association between adiponectin and endometriosis 2024
- <i>CircFOXO3</i> mediates hypoxia‐induced autophagy of endometrial stromal cells in endometriosis 2024
- Efferocytosis and infertility: Implications for diagnosis and therapy 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Autophagy-dependent ferroptosis is involved in the development of endometriosis 2023
- Hyaluronic Acid-Modified Nanoplatforms as a Vector for Targeted Delivery of Autophagy-Related Gene to the Endometriotic Lesions in Mice 2022
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies 2021
- THE INFLUENCE OF ENDOMETRIOID HETEROTOPIAS ON THE RED BLOOD PARAMETERS 2020
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:41.077124+00:00
License: CC0
· commercial use OK